Collateral Plus, LLC v. Max Well Medical, Inc.

CourtCourt of Appeals of Tennessee
DecidedMarch 29, 2011
DocketM2010-00638-COA-R3-CV
StatusPublished

This text of Collateral Plus, LLC v. Max Well Medical, Inc. (Collateral Plus, LLC v. Max Well Medical, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Collateral Plus, LLC v. Max Well Medical, Inc., (Tenn. Ct. App. 2011).

Opinion

IN THE COURT OF APPEALS OF TENNESSEE AT NASHVILLE October 14, 2010 Session

COLLATERAL PLUS, LLC, ET AL. v. MAX WELL MEDICAL, INC.

Appeal from the Chancery Court for Davidson County No. 08-2534-II Carol L. McCoy, Chancellor

No. M2010-00638-COA-R3-CV - Filed March 29, 2011

This is an appeal of the grant of a motion for summary judgment. The parties entered into a loan management agreement providing that a placement fee would be paid only upon the occurrence of certain conditions. The agreement explicitly provided that it would terminate when the underlying bank loan was satisfied. When the underlying loan was repaid, the conditions precedent to the payment of the placement fee had not occurred. The Appellee sought payment of the placement fee when the Appellant was acquired a year later, which the Appellant refused on the grounds that the agreement had terminated. Because the agreement states unequivocally that it terminates upon repayment of the underlying loan, making the placement fee provision unenforceable, we reverse the summary judgment award in favor of the Appellee. We hold that, instead, summary judgment should have been entered in favor of the Appellant.

Tenn. R. App. P. 3 Appeal as of Right; Judgment of the Chancery Court Reversed

P ATRICIA J. C OTTRELL, P.J., M.S., delivered the opinion of the Court, in which A NDY D. B ENNETT, J., joined. R ICHARD H. D INKINS, J., dissenting.

Michael L. Dagley, Joshua R. Denton, Wendee M. Hilderbrand, Nashville, Tennessee, for the appellant, MAX Well Medical, Inc.

Robert J. Walker, John C. Hayworth, Erin Palmer Polly, Nashville, Tennessee, for the appellees, Collateral Plus, L.L.C., and Collateral Guaranty Fund, L.P. OPINION

I. B ACKGROUND

In this contract dispute, Collateral Plus, L.L.C. and Collateral Guaranty Fund, L.P. (collectively, “Collateral”) entered into a Loan Management Agreement (“LMA”) with MAX Well Medical, Inc. (“MAX Well”) dated January 12, 2006. MAX Well was in financial distress, and Collateral offered to assist MAX Well to obtain refinancing and additional working capital. Collateral is in the business of providing credit enhancements to emerging and growth stage companies that have difficulty obtaining traditional bank financing. Typically, Collateral enhances the credit worthiness of borrowers by providing letters of credit and guarantees of debt.

Pursuant to the terms of the LMA, Collateral provided letters of credit and other credit enhancements and agreed to act as paying agent for a line of credit from SunTrust Bank to MAX Well up to $4,500,000. In consideration for supplying these guarantees, credit enhancements, and facilitating the line of credit, MAX Well agreed to pay Collateral certain fees. The fees included a restructuring fee of $90,000 payable at closing, a commitment fee of $90,000 payable at closing, a monthly advisory fee of $7,500, a monthly funding fee of one percent of the outstanding balance, and other incidental fees and excess interest payments. The LMA also provided for “a placement fee of $900,000.00, payable upon a change of control of [MAX Well], sale of [MAX Well], or the acquisition of [MAX Well’s] assets.”

The LMA included a section entitled “Term,” which provided in part:

This Agreement shall be effective as of the date first written above and shall continue in full force and effect until such time as [MAX Well’s] indebtedness with respect to the Loan has been paid in full. . . . [I]f [MAX Well] is not then in breach of the Loan and there has not been a material adverse change with respect to the business or assets of [MAX Well], then [Collateral], shall work to refinance the balance of the Loan for an additional eleven (11) months. Upon such extension, [MAX Well] shall pay to [Collateral] a one percent (1%) renewal fee and all other fees including but not limited to the additional interest rate spread of three percent (3%) on the outstanding balance paid monthly, the advisory fee of $7,500.00 per month, and the funding fee of one percent (1%) on the outstanding balance paid monthly. There will be no restructure fee or commitment fee on the renewal but the placement fee due on the sale of [MAX Well] will remain in place.

-2- The parties agree MAX Well could not have survived financially for more than a month or so without the debt guaranty from Collateral and the loan from SunTrust Bank. When MAX Well and Collateral were working out the terms of the LMA, MAX Well was in discussions with another company regarding a put/call option whereby the other company could acquire MAX Well if certain financial performance targets were met. When the parties executed the LMA, both Collateral and MAX Well assumed that MAX Well would either be sold to this other company pursuant to the put/call option agreement or that MAX Well would simply go out of business.

A company called Fresenius Medical Care North America (“Fresenius”) acquired the holder of the put/call agreement, and in February, 2007, Fresenius joined Specialty Care Services Group (“SCSG”) to acquire thirty-one percent of MAX Well’s outstanding stock (“31% Transaction”). As part of this 31% Transaction, Fresenius and SCSG guaranteed $4 million of new debt taken on by MAX Well. This new debt allowed MAX Well to pay off the balance of the $4.5 million line of credit that was the subject of the LMA. On March 15, 2007, MAX Well paid off all outstanding indebtedness on the bank loan.

Approximately one year later, on or about February 29, 2008, Fresenius purchased the remaining sixty-nine percent of MAX Well (“69% Transaction”). Thereafter, Collateral demanded its $900,000 placement fee. MAX Well declined to pay this fee on the basis that the LMA had terminated by its own terms on March 15, 2007, when MAX Well paid off the outstanding balance of its $4.5 million line of credit. Therefore, according to MAX Well, the conditions triggering its obligation to pay the $900,000 placement fee were not satisfied prior to the LMA’s termination. This lawsuit followed.

While the parties were engaged in discovery, MAX Well sought information from Collateral regarding Collateral’s usual and prior treatment of and expectations with regard to fees similar to the placement fee in other contracts similar to the LMA. Collateral objected to MAX Well’s requests, claiming extrinsic evidence about Collateral’s typical fee structures was irrelevant, because the LMA was unambiguous and the court need look no further than the four corners of the LMA to determine whether or not the placement fee was payable. MAX Well filed a motion to compel, which the trial court denied based on both MAX Well’s and Collateral’s contentions that the LMA was unambiguous, rendering parol evidence inadmissible.

MAX Well then moved for summary judgment, arguing that according to the plain language of the LMA, the $900,000 placement fee was a conditional obligation that did not survive the termination of the LMA. According to MAX Well, the express terms of the LMA provided that the LMA terminated when MAX Well paid the outstanding portion of its $4.5 million debt. In the absence of a clause specifying that the placement fee was meant

-3- to survive the termination of the LMA, MAX Well argued the termination provision of the LMA applied to the entire agreement, including MAX Well’s obligation to pay Collateral the placement fee. Collateral filed a cross-motion for summary judgment. Collateral argued the $900,000 placement fee was an obligation MAX Well incurred upon the execution of the LMA, and that it became payable in February 2008, when Fresenius acquired the remaining 69% of MAX Well. Collateral agreed with MAX Well that the remainder of the LMA terminated when MAX Well repaid its loan in March 2007.

II. T RIAL C OURT’S R ULING

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Whaley v. Perkins
197 S.W.3d 665 (Tennessee Supreme Court, 2006)
Boyd v. Comdata Network, Inc.
88 S.W.3d 203 (Court of Appeals of Tennessee, 2002)
Marshall v. Jackson & Jones Oils, Inc.
20 S.W.3d 678 (Court of Appeals of Tennessee, 1999)
Blair v. Brownson
197 S.W.3d 681 (Tennessee Supreme Court, 2006)
Bob Pearsall Motors, Inc. v. Regal Chrysler-Plymouth, Inc.
521 S.W.2d 578 (Tennessee Supreme Court, 1975)
Petty v. Sloan
277 S.W.2d 355 (Tennessee Supreme Court, 1955)
Hardeman County Bank v. Stallings
917 S.W.2d 695 (Court of Appeals of Tennessee, 1995)
Hillsboro Plaza Enterprises v. Moon
860 S.W.2d 45 (Court of Appeals of Tennessee, 1993)
Planters Gin Co. v. Federal Compress & Warehouse Co.
78 S.W.3d 885 (Tennessee Supreme Court, 2002)
Maggart v. Almany Realtors, Inc.
259 S.W.3d 700 (Tennessee Supreme Court, 2008)
Frizzell Construction Co. v. Gatlinburg, L.L.C.
9 S.W.3d 79 (Tennessee Supreme Court, 1999)
Angus v. Western Heritage Insurance Co.
48 S.W.3d 728 (Court of Appeals of Tennessee, 2000)
Guiliano v. Cleo, Inc.
995 S.W.2d 88 (Tennessee Supreme Court, 1999)
Parker v. Union Planters Corp.
203 F. Supp. 2d 888 (W.D. Tennessee, 2002)
Berry v. Prudential Ins. Co. of America
134 S.W.2d 886 (Court of Appeals of Tennessee, 1939)

Cite This Page — Counsel Stack

Bluebook (online)
Collateral Plus, LLC v. Max Well Medical, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/collateral-plus-llc-v-max-well-medical-inc-tennctapp-2011.